Evaluation des campagnes de prévention du SIDA en Suisse : rapport intermédiaire : (juillet 1988)

Le présent rapport intermédiaire concerne l'impact de la suite de la campagne STOP-SIDA et des autres aspects de la prévention (actions multiplicatrices, compléments à la campagne STOP-SIDA), à partir du mois d'octobre 1987. Il fait référence entre autres à la phase III de STOP-SIDA: répétition des messages des phases I et II (usage du préservatif, non-échange de matériel d'injection, fidélité) et situations sans risque de contamination. Les données présentées sont le résultat d'une synthèse préliminaire basée sur des études en cours de réalisation, elles ne peuvent donc être interprétées qu'en termes de premières tendances ou impressions, qui devront encore être confirmées ou infirmées par l'achèvement des études. Elles permettent cependant de formuler quelques conclusions et recommandations. [Auteurs, p. 5-6]

[Archives de la parole]. , [Valse du Père Cadet] / [Ferdinand Brunot], collecteur ; [Pierre Appaire, 49 ans, cornemuseux], cornemuse ; [Bertrand Appaire, vielleux], vielle ; [Pierre Gerbaud, 61 ans, vielleux], vielle. [Une chasse ancienne] / [Ferdinand Brunot], collecteur ; [Pierre Appaire, 49 ans, cornemuseux], cornemuse

[Traditions. France. Berry]

Argemone mexicana decoction versus artesunate-amodiaquine for the management of malaria in Mali: policy and public-health implications.

A classic way of delaying drug resistance is to use an alternative when possible. We tested the malaria treatment Argemone mexicana decoction (AM), a validated self-prepared traditional medicine made with one widely available plant and safe across wide dose variations. In an attempt to reflect the real situation in the home-based management of malaria in a remote Malian village, 301 patients with presumed uncomplicated malaria (median age 5 years) were randomly assigned to receive AM or artesunate-amodiaquine [artemisinin combination therapy (ACT)] as first-line treatment. Both treatments were well tolerated. Over 28 days, second-line treatment was not required for 89% (95% CI 84.1-93.2) of patients on AM, versus 95% (95% CI 88.8-98.3) on ACT. Deterioration to severe malaria was 1.9% in both groups in children aged </=5 years (there were no cases in patients aged >5 years) and 0% had coma/convulsions. AM, now government-approved in Mali, could be tested as a first-line complement to standard modern drugs in high-transmission areas, in order to reduce the drug pressure for development of resistance to ACT, in the management of malaria. In view of the low rate of severe malaria and good tolerability, AM may also constitute a first-aid treatment when access to other antimalarials is delayed.

Parasitism on Eriosoma lanigerum (Homoptera: Aphididae) by Aphelinus mali (Hymenoptera: Encyrtidae) on apple orchards, in Fraiburgo county, state of Santa Catarina, Brazil

The parasitism of the woolly apple aphid (Eriosoma lanigerum Hausmann) by Aphelinus mali (Hald.) was evaluated in apple orchards cultivated with the varieties Gala and Fuji in Fraiburgo County, State of Santa Catarina, Southern Brazil. Colonies of the woolly apple aphid were evaluated during one year on 16 apple trees of each variety, starting in August 1999. The number of aphids at the mummy stage or presenting the orifice of the parasitoid emergence was recorded. Results have shown that A. mali parasitized more than 50% of the woolly apple aphids and occurred during the four seasons. It was concluded that that under these conditions no chemical control against the aphid is necessary for the apple varieties Gala and Fuji.